Who owns BUCHER JAMES B?

No ownership or control links for BUCHER JAMES B are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is BUCHER JAMES B's risk level?

WhiteIntel flags BUCHER JAMES B as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does BUCHER JAMES B appear across sources?

BUCHER JAMES B is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Legal entityLow

BUCHER JAMES B

Name: BUCHER JAMES B — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, BUCHER JAMES B, Company, US

BUCHER JAMES B — US company (sec:0001664928). 4 holdings. Every claim linked to its source.

SEC 0001664928CompanyUS

Ownership graph Export .md

JSON / MCPsample

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

None in current sources.

Holdings / subsidiaries

BUCHER JAMES B
- Zentalis Pharmaceuticals, Inc.· officer· via SEC EDGAR
- HARPOON THERAPEUTICS, INC.· officer· via SEC EDGAR
- Climb Bio, Inc.· officer· via SEC EDGAR
- ALDER BIOPHARMACEUTICALS INC· officer· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for BUCHER JAMES B — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of BUCHER JAMES B is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on BUCHER JAMES B is behind a paywall — everything we hold on this subject is already on this page.

/02

People & control

4 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
ALDER BIOPHARMACEUTICALS INC
Also holds roles at 70 other companies
- HASSLER RANDALofficer
- Redmile Group, LLCdirector
- H LUNDBECK A Stenpercentowner
●
Climb Bio, Inc.
Also holds roles at 40 other companies
- Thomas Stephen Basildirector
- Pimblett Emilyofficer
- Brennan Aoifeofficer
●
HARPOON THERAPEUTICS, INC.
Also holds roles at 61 other companies
- Robbins Andrew Rdirector
- EASTLAND JULIA MARIEofficer
- DRACHMAN JONATHAN Gdirector
●
Zentalis Pharmaceuticals, Inc.
Also holds roles at 43 other companies
- Bruns Ingmarofficer
- Vultaggio Vincentofficer
- Lackner Markofficer

4 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns BUCHER JAMES B?: No ownership or control links for BUCHER JAMES B are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is BUCHER JAMES B's risk level?: WhiteIntel flags BUCHER JAMES B as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does BUCHER JAMES B appear across sources?: BUCHER JAMES B is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on BUCHER JAMES B. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…